AN UNPUBLISHED AMENHOTEP-III FAIENCE PLAQUE FROM MYCENAE

被引:10
作者
CLINE, E
机构
关键词
D O I
10.2307/604526
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
引用
收藏
页码:200 / 212
页数:13
相关论文
共 50 条
  • [31] Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies
    Lebwohl, Mark
    Iversen, Lars
    Eidsmo, Liv
    Krueger, James G.
    Suarez-Farinas, Mayte
    Tomalin, Lewis
    Kolbinger, Frank
    You, Ruquan
    Milutinovic, Marina
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 49 (08) : 793 - 800
  • [32] Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial
    Leonardi, CL
    Papp, KA
    Gordon, KB
    Menter, A
    Feldman, SR
    Caro, I
    Walicke, A
    Compton, PG
    Gottlieb, AB
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : 425 - 433
  • [33] Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies
    Archie W. Thurston
    David W. Osborne
    Scott Snyder
    Robert C. Higham
    Patrick Burnett
    David R. Berk
    American Journal of Clinical Dermatology, 2023, 24 : 315 - 324
  • [34] Bimekizumab in patients with moderate-to-severe plaque psoriasis by bodyweight: pooled results from phase III trials
    Pinter, A.
    Strober, B.
    Rosmarin, D.
    Gisondi, P.
    Vanvoorden, V.
    Peterson, L.
    Madden, C.
    de Cuyper, D.
    Warren, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E48 - E49
  • [35] Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
    Lebwohl, Mark
    Warren, Richard B.
    Sofen, Howard
    Imafuku, Shinichi
    Paul, Carle
    Szepietowski, Jacek C.
    Spelman, Lynda
    Passeron, Thierry
    Vritzali, Eleni
    Napoli, Andrew
    Kisa, Renata M.
    Buck, Alex
    Banerjee, Subhashis
    Thaci, Diamant
    Blauvelt, Andrew
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (05) : 668 - 679
  • [36] The role of Enea Silvio Piccolomini in the diplomatic relations between Siena and Callisto III. Unpublished letters from the Siena State Archives
    Saviano, Rita
    RETI MEDIEVALI RIVISTA, 2021, 22 (01): : 429 - 463
  • [37] Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study
    Wu, Nan-Lin
    Hsu, Chih-Jung
    Sun, Fang-Ju
    Tsai, Tsen-Fang
    JOURNAL OF DERMATOLOGY, 2017, 44 (10) : 1129 - 1137
  • [38] Safety of extended and long-term efalizumab therapy for plaque psoriasis: Results from phase III clinical trials
    Carey, W
    Menter, A
    Leonardi, C
    Lynde, C
    Ouellet, J
    Toth, D
    Rosoph, L
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [39] Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
    Strober, Bruce
    Zhao, Yang
    Tran, Mary Helen
    Gnanasakthy, Ari
    Nyirady, Judit
    Papavassilis, Charis
    Nelson, Lauren M.
    McLeod, Lori D.
    Mordin, Margaret
    Gottlieb, Alice B.
    Elewski, Boni E.
    Lebwohl, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (03) : E147 - E155
  • [40] Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
    Kimball, A. B.
    Papp, K. A.
    Reich, K.
    Gooderham, M.
    Li, Q.
    Cichanowitz, N.
    La Rosa, C.
    Blauvelt, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (06) : 1359 - 1368